Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1341-1350 of 1,467) with videos related to

Pageof 147
Sort By:
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Annals of the Rheumatic Diseases|June 21, 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritisMaximilian Kugler, Mirjam Dellinger, Felix Kartnig, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels, Rachel Knevel, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
The Journal of Rheumatology|January 17, 2019
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT InitiativeSabrina M Nielsen, Peter Tugwell, Maarten P T de Wit, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Frontiers in Immunology|April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive TherapyAlessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
Annals of the Rheumatic Diseases|November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesM Mosca, C Tani, M Aringer, et al.
Pageof 147

Showing results (1341-1350 of 1,467) with videos related to

Sort By:
Pageof 147
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newbornsAvy Violari, Kennedy Otwombe, William Hahn, et al.
Annals of the Rheumatic Diseases|June 21, 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritisMaximilian Kugler, Mirjam Dellinger, Felix Kartnig, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels, Rachel Knevel, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
The Journal of Rheumatology|January 17, 2019
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT InitiativeSabrina M Nielsen, Peter Tugwell, Maarten P T de Wit, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Frontiers in Immunology|April 18, 2022
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive TherapyAlessandra Ruggiero, Giuseppe Rubens Pascucci, Nicola Cotugno, et al.
Annals of the Rheumatic Diseases|November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesM Mosca, C Tani, M Aringer, et al.
Pageof 147